What does GCANRx do?
Aitan Zacharin: “GCANRx is a biopharmaceutical company leading the industry in innovative cannabinoid delivery systems. We have taken our decades of R&D in drug delivery technologies and have found a very relevant application for it in the cannabis space. We develop and manufacture a number of products on our eluting transmucosal patch platform. Our technology, in essence, is a mucoadhesive oral thin film, which using our proprietary system delivers APIs (in this case cannabinoids) through the oral mucosa into the blood steam. To a high degree it allows the actives we load it with to bypass the GI track and liver metabolism. It’s an effective and safe delivery system that has been studied extensively and substantiated across many applications.”
What is the next big goal GCAN is trying to accomplish and what should we keep an eye out for?
Aitan Zacharin: “We are seeking partnerships with a number of companies to commercialize our products ranging from consumer products companies, LPs, and pharmaceutical companies focused on the cannabis industry. Additionally, we are continuing to develop innovative products using our intellectual property. We have a number of new products and formulations including a disruptive beauty and health product.”
Why did you join the OTCQB and go public?
Aitan Zacharin: “The OTCQB offers us exposure to a tier of investors that look for real public companies to invest in. In contrast to many broad business development companies on the lower tier exchanges, GCANRx is a real company with a real business. It is important for us to attract the right retail and institutional investor who is looking to diversify across the cannabis sector. The greater level of scrutiny that a reporting OTCQB company must undergo helps us attract a higher caliber and more sophisticated investor. That was one driving factor that led us to uplist to the OTCQB.”
How can members of the microcap community help you?
Aitan Zacharin: “We’re always looking to build our base of investors. It would be great to have a group of investors that will take the time to research the cannabis industry, and they will surely find that new, safe, and standardized delivery systems is the next big wave of innovation in the industry. We are at the forefront of that, and as such we expect our valuation to grow in lockstep with the growth of the industry. Having investors that recognize that, and believe in our technology and our ability to execute will be helpful to our overall growth strategy.”
Learn more at: https://www.gcanrx.com/
QBie™ Spotlight is a virtual “welcome interview” for new OTCQB companies. QBie™ Spotlight helps issuers that are new to the OTCQB connect with microcap industry professionals, for free! Learn more about the QBie™ Spotlight HERE.
Disclaimer/Forward Looking Statements:
This Website and its contents are not to be construed, under any circumstances, as an offer to sell or a solicitation to buy or effect transactions in any securities. No investment advice is provided or should be construed to be provided herein. This Website and its owners, employees and affiliates are not, nor do any of them claim to be, registered broker-dealers or registered investment advisors. This Website may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including, but not limited to, any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Such forward-looking statements of or concerning the companies mentioned herein are subject to numerous uncertainties and risk factors, including uncertainties and risk factors that may not be set forth herein, which could cause actual results to differ materially from those stated herein. Accordingly, user of this Website are cautioned not to place undue reliance on such forward-looking statements. This Website undertakes no obligation to update any forward-looking statements that may be contained herein.